Individual holder
SRIVASTAVA SURESH C
US·12 granted patents·5 pending applications·22 citations·filing 1984–2020
Individually held — no corporate assignee on record.
Top patents by PatentIndex Score
17 records- 0185US8309707B2RNA synthesis-phosphoramidites for synthetic RNA in the reverse direction, and application in convenient introduction of ligands, chromophores and modifications of synthetic RNA at the 3′-endSRIVASTAVA SURESH C·Filed 2009·Granted Nov 13, 2012·9 cites·3 claims
- 0283US8541569B2Phosphoramidites for synthetic RNA in the reverse direction, efficient RNA synthesis and convenient introduction of 3'-end ligands, chromophores and modifications of synthetic RNASRIVASTAVA SURESH C·Filed 2010·Granted Sep 24, 2013·9 cites·32 claims
- 0373US9045521B2Synthesis of deuterated ribo nucleosides N-protected phosphoramidites, and oligonucleotidesSRIVASTAVA SURESH C·Filed 2012·Granted Jun 2, 2015·1 cites·36 claims
- 0461US8114264B2Method of electroplating a conversion electron emitting source on implantSRIVASTAVA SURESH C·Filed 2007·Granted Feb 14, 2012·0 cites·16 claims
- 0560US8518992B2Method of synthesis and purification of N-6-trimethyl-L-lysine and derivative compoundsSRIVASTAVA SURESH C·Filed 2011·Granted Aug 27, 2013·0 cites·2 claims
- 0658US8778996B2Method of treating a human being for a class of neurological defects and seizure disordersSRIVASTAVA SURESH C·Filed 2011·Granted Jul 15, 2014·0 cites·2 claims
- 0755US8981076B2Synthesis of N-FMOC protected deoxy nucleosides, ribo nucleosides, modified deoxy and ribo nucleosides, and phosphoramidites, and their use in oligonucleotide synthesisSRIVASTAVA SURESH C·Filed 2009·Granted Mar 17, 2015·0 cites·3 claims
- 0854US8389577B2Method of treating a human being for a class of metabolic defects and energy production disordersSRIVASTAVA SURESH C·Filed 2011·Granted Mar 5, 2013·0 cites·2 claims
- 0954US2021355551A1RT-qPCR Molecular Detection and Diagnosis of 2019 Novel CoronavirusSRIVASTAVA SURESH C·Filed 2020·Application pending·0 cites
- 1053US8859754B2Synthesis of deuterated ribo nucleosides, N-protected phosphoramidites, and oligonucleotidesSRIVASTAVA SURESH C·Filed 2012·Granted Oct 14, 2014·0 cites·25 claims
- 1152US2012109287A1Method of electroplating a conversion electron emitting source on implantSRIVASTAVA SURESH C·Filed 2011·Application pending·0 cites
- 1248US2011040082A1Modifications of antimetabolite gemcitabine for incorporation in CpG oligonucleotidesSRIVASTAVA SURESH C·Filed 2010·Application pending·0 cites
- 1345US9884885B2Synthesis of labile base protected-modified deoxy and modified ribo nucleosides, corresponding phosphoramidites and supports and their use in high purity oligonucleotide synthesisSRIVASTAVA SURESH C·Filed 2010·Granted Feb 6, 2018·0 cites·5 claims
- 1438US8705681B2Process and targets for production of no-carrier-added radiotinSRIVASTAVA SURESH C·Filed 2007·Granted Apr 22, 2014·0 cites·32 claims
- 1534US2015018579A1Synthesis of high purity dmt-c3-disulfide phosphoramiditeSRIVASTAVA SURESH C·Filed 2012·Application pending·0 cites
- 1634US2012149888A1Synthesis of ara-2'-o-methyl-nucleosides, corresponding phosphoramidites and oligonucleotides incorporating novel modifications for biological application in therapeuctics, diagnostics, g- tetrad forming oligonucleotides and aptamersSRIVASTAVA SURESH C·Filed 2010·Application pending·0 cites
- 1733USH819HPalladium-109 labeled anti-melanoma monoclonal antibodiesSRIVASTAVA SURESH C·Filed 1984·Granted Sep 4, 1990·3 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when SRIVASTAVA SURESH C files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →